{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:54:53Z","timestamp":1772117693768,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd009014","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T00:00:00Z","timestamp":1347408000000}}],"reference-count":61,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009014.pub2","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T18:38:34Z","timestamp":1346783914000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Allergen-specific oral immunotherapy for peanut allergy"],"prefix":"10.1002","volume":"2012","author":[{"given":"Ulugbek","family":"Nurmatov","sequence":"first","affiliation":[{"name":"Centre for Population Health Sciences, The University of Edinburgh; Allergy & Respiratory Research Group; 20 West Richmond Street Edinburgh UK EH8 9DX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Venderbosch","sequence":"additional","affiliation":[{"name":"Radboud University Nijmegen Medical Center; PO Box 9101 Nijmegen Netherlands 6500 HB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Devereux","sequence":"additional","affiliation":[{"name":"The University of Aberdeen; Department of Child Health, Royal Aberdeen Children's Hospital; Foresterhill Road Aberdeen Scotland UK AB25 2ZP"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F Estelle R","family":"Simons","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Manitoba; Department of Pediatrics & Child Health; Department of Immunology; Winnipeg Manitoba Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[{"name":"The University of Edinburgh; Centre for Population Health Sciences; Medical School Doorway 3, Teviot Place Edinburgh UK EH8 9AG"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"key":"10.1002\/14651858.CD009014.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2010.12.1111","article-title":"A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response","volume":"127","author":"Varshney","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9","key":"10.1002\/14651858.CD009014.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2222.2011.03699.x","article-title":"Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome","volume":"41","author":"Anagnostou","year":"2011","journal-title":"Clinical & Experimental Allergy"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0003|cit3","first-page":"167","article-title":"Oral specific desensitisation in food allergy and loss of tolerance after interruption of the maintenance phase: five case reports","volume":"64 (Suppl.90)","author":"Aruanno","year":"2009","journal-title":"Allergy"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"AB20","DOI":"10.1016\/j.jaci.2009.12.110","article-title":"Double-blinded placebo controlled sublingual immunotherapy (SLIT) trial for peanut allergy","volume":"125","author":"Bird","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaci.2010.04.030","article-title":"Oral peanut immunotherapy in children with peanut anaphylaxis","volume":"126","author":"Blumchen","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1016\/j.jaci.2005.12.1290","article-title":"Oral desensitization and induction of tolerance in peanut-allergic children","volume":"117","author":"Buchanan","year":"2006","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"8","key":"10.1002\/14651858.CD009014.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1398-9995.2009.01982.x","article-title":"Successful oral tolerance induction in severe peanut allergy","volume":"64","author":"Clark","year":"2009","journal-title":"Allergy"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaci.2009.03.045","article-title":"Safety of a peanut oral immunotherapy protocol in children with peanut allergy","volume":"124","author":"Hofmann","year":"2009","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaci.2009.05.022","article-title":"Clinical efficacy and immune regulation with peanut oral immunotherapy","volume":"124","author":"Jones","year":"2009","journal-title":"Journal of Allergy and Clinical Imunology"},{"issue":"3","key":"10.1002\/14651858.CD009014.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jaci.2010.12.1083","article-title":"Sublingual immunotherapy for peanut allergy: clinical and immunological evidence of desensitization","volume":"127","author":"Kim","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1081-1206(10)60026-9","article-title":"Sussessful oral desensitisation for systemic peanut allergy","volume":"97","author":"Mansfield","year":"2006","journal-title":"Annals of Allergy,\u00a0Asthma\u00a0and\u00a0Immunology"},{"issue":"5","key":"10.1002\/14651858.CD009014.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.reval.2010.04.003","article-title":"Efficiency and safety of oral immunotherapy protocols in peanut allergy: Pilot study on 51 patients","volume":"50","author":"Moneret-Vautrin","year":"2010","journal-title":"Revue Fran\u00e7aise d'Allergologie\u00a0et d'Immunologie Clinique"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/j.jaci.2007.12.544","article-title":"Oral immunotherapy for children with peanut allergy","volume":"121","author":"Nash","year":"2008","journal-title":"Journal of Allergy and Clinical immunology"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0014|cit14","first-page":"AB21","article-title":"Immunoglobulin changes using different dosing regimens of peanut oral immunotherapy (OIT) in peanut allergic patients","volume":"125","author":"Thyagarajan","year":"2008","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"AB59(233)","DOI":"10.1016\/j.jaci.2009.12.954","article-title":"Office based oral desensitization of patients with anaphylactic sensitivity to foods is safe and effective","volume":"125","author":"Wassermann","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"AB25","DOI":"10.1016\/j.jaci.2010.12.109","article-title":"THe safety of peanut oral immunotherapy in peanut allergic subjects in a single center trial","volume":"127","author":"Weldon","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0017|cit17","unstructured":"Study of the effectiveness of Probiotics and Peanut Oral Immunotherapy (P-POIT) in inducing desensitisation or tolerance in children with peanut allergy Ongoing study December 2008"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0018|cit18","unstructured":"Oral Peanut Immunotherapy for Peanut Allergic Patients Ongoing study March 2003"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0019|cit19","unstructured":"Oral Immunotherapy for Peanut Allergy Ongoing study June 2009"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0020|cit20","unstructured":"Peanut Oral Immunotherapy and Anti-IgE for Peanut Allergy Ongoing study July 2009"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0021|cit21","unstructured":"A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual\/Oral Immunotherapy for the Treatment of Peanut Allergy Ongoing study March 2010"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0022|cit22","unstructured":"Efficacy and Safety of High-dose Peanut Oral Immunotherapy With Factors Predicting Outcome Ongoing study Jan 2008"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0023|cit23","unstructured":"Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults Ongoing study Dec 2010"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0024|cit24","unstructured":"Oral Peanut Immunotherapy Ongoing study March 2011"},{"issue":"8","key":"10.1002\/14651858.CD009014.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1365-2222.2007.02758.x","article-title":"The psychosocial impact of anaphylaxis on young people and their parents","volume":"37","author":"Akeson","year":"2007","journal-title":"Clinical and Experimantal Allergy"},{"issue":"4","key":"10.1002\/14651858.CD009014.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"4","key":"10.1002\/14651858.CD009014.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jaci.2009.02.004","article-title":"Is the prevalence of peanut allergy increasing? A 5-year follow-up study in children in Montreal","volume":"123","author":"Ben-Shoshan","year":"2009","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0140-6736(08)60659-5","article-title":"Peanut allergy","volume":"371","author":"Burks","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD009014.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-2222.2011.03835.x","article-title":"Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis","volume":"41","author":"Calderon","year":"2011","journal-title":"Clinical and Experimental Allergy"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.iac.2011.02.002","article-title":"Immunotherapy: The meta-analysis. What have we learned?","volume":"31","author":"Calderon","year":"2011","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaci.2008.05.015","article-title":"Good prognosis, clinical features, and circumstances of peanut and tree nut reactions in children treated by a specialist allergy center","volume":"122","author":"Clark","year":"2008","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1399-3038.2009.00975.x","article-title":"Management of nut allergy influences quality of life and anxiety in children and their mothers","volume":"21","author":"Cummings","year":"2010","journal-title":"Pediatric Allergy and Immunology"},{"issue":"1","key":"10.1002\/14651858.CD009014.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000208","article-title":"The peanut allergy epidemic: Allergen molecular characterisation and prospects for specific therapy","volume":"9","author":"Leon","year":"2007","journal-title":"Expert Reviews in Molecular Medicine"},{"issue":"7121","key":"10.1002\/14651858.CD009014.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: principles and procedures","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/adc.2009.172460","article-title":"Specific oral tolerance induction in food allergic children: is oral desensitisation more effective than allergen avoidance","volume":"96","author":"Fisher","year":"2011","journal-title":"Archives of Disease in Childhood"},{"issue":"6","key":"10.1002\/14651858.CD009014.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2222.2011.03743.x","article-title":"Epinephrine auto-injector use in adolescents at risk of anaphylaxis: a qualitative study in Scotland, UK","volume":"41","author":"Gallagher","year":"2011","journal-title":"Clinical and Experimental Allergy"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0037|cit37","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions\u00a0Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011, available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jaci.2006.12.670","article-title":"The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry","volume":"119","author":"Hourihane","year":"2007","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1002\/14651858.CD009014.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1398-9995.2008.01843.x","article-title":"Impact of peanut allergy on quality of life, stress and anxiety in the family","volume":"64","author":"King","year":"2009","journal-title":"Allergy"},{"issue":"3","key":"10.1002\/14651858.CD009014.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jaci.2010.11.021","article-title":"Incidence, prevalence, and trends of general practitioner-recorded diagnosis of peanut allergy in England, 2001-2005","volume":"127","author":"Kotz","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.reval.2011.01.026","article-title":"Sublingual and oral immunotherapy for food allergy: outcome and immunological modifications","volume":"51","author":"Moneret-Vautrin","year":"2011","journal-title":"Review Francaise D'Allergologie"},{"issue":"3","key":"10.1002\/14651858.CD009014.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaci.2008.12.1116","article-title":"Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007","volume":"123","author":"Mullins","year":"2009","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD009014.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0091-6749(97)80006-1","article-title":"Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract","volume":"99","author":"Nelson","year":"1997","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD009014.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaci.2009.10.008","article-title":"Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics","volume":"125","author":"Nicolaou","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009014","article-title":"Oral immunotherapy for peanut allergy","author":"Nurmatov","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0091-6749(92)90080-L","article-title":"Treatment of peanut allergy with rush immunotherapy","volume":"90","author":"Oppenheimer","year":"1992","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaci.2011.01.039","article-title":"Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants","volume":"127","author":"Osborne","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD009014.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2009.05.027","article-title":"Summary of the 2008 National Institute of Allergy and Infectious Diseases-US Food and Drug Administration Workshop on Food Allergy Clinical Trial Design","volume":"124","author":"Plaut","year":"2009","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"12","key":"10.1002\/14651858.CD009014.pub2-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002893.pub2","article-title":"Sublingual immunotherapy for allergic rhinitis","author":"Radulovich","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(00)67313-0","article-title":"A Case of Egg Poisoning","volume":"171","author":"Schofield","year":"1908","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009014.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"c2938","DOI":"10.1136\/bmj.c2938","article-title":"Oral immunotherapy for peanut allergy","volume":"340","author":"Sheikh","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD009014.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4104\/pcrj.2011.00071","article-title":"Oral immunotherapy for the treatment of peanut allergy: systematic review of six case series studies","volume":"21","author":"Sheikh","year":"2012","journal-title":"Primary Care Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S470","DOI":"10.1016\/j.jaci.2005.05.048","article-title":"Food allergy","volume":"117","author":"Sicherer","year":"2006","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1002\/14651858.CD009014.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2007.07.015","article-title":"Peanut allergy: emerging concepts and approaches for an apparent epidemic","volume":"120","author":"Sicherer","year":"2007","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"10.1002\/14651858.CD009014.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jaci.2010.03.029","article-title":"US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up","volume":"125","author":"Sicherer","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD009014.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.jaci.2009.08.028","article-title":"Food allergy","volume":"125","author":"Sisherer","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD009014.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jaci.2009.08.025","article-title":"Anaphylaxis: recent advances in assessment and treatment","volume":"124","author":"Simons","year":"2009","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1002\/14651858.CD009014.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"587-93, e1-22","DOI":"10.1016\/j.jaci.2011.01.038","article-title":"World Allergy Organization anaphylaxis guidelines: Summary","volume":"127","author":"Simons","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.resuscitation.2008.02.001","article-title":"Emergency treatment of anaphylactic reactions-guidelines for healthcare providers. Working Group of the Resuscitation Council (UK)","volume":"77","author":"Soar","year":"2008","journal-title":"Resuscitation"},{"issue":"1","key":"10.1002\/14651858.CD009014.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaci.2010.05.012","article-title":"Peanut oral immunotherapy is not ready for clinical use","volume":"126","author":"Thyagarajan","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD009014.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2006.04.024","article-title":"Accidental ingestions in children with peanut allergy","volume":"118","author":"Yu","year":"2006","journal-title":"Journal of Allergy and Clinical Immunology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009014.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:50:46Z","timestamp":1722246646000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009014.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Tobacco Addiction Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":61,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2012,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009014.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717958420.793463568","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717958420.793463685","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717958420.793464036","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,12]]}}}